Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

320.42

+1.51 (0.47%)

At close: Mar 17, 2026, 4:00 PM EDT

320.14

-0.28 (-0.09%)

After-hours: Mar 17, 2026, 5:43 PM EDT

Alnylam Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	313.75	-278.16	-440.24	-1,131	-852.82
Depreciation & Amortization	55.66	56.67	54.05	44.47	47.57
Stock-Based Compensation	348.24	272.08	221.68	230.65	165.72
Other Adjustments	251.22	155.18	211.4	307.15	160.67
Change in Receivables	-359.96	-86.55	-87.94	-45.6	-101.8
Changes in Inventories	8.47	13.59	18.37	-34.14	-26.42
Changes in Accounts Payable	75.07	91.09	80.84	191.77	88.24
Changes in Unearned Revenue	-50.64	-235.45	55.02	-65.91	-50.4
Changes in Other Operating Activities	-117.72	3.23	-9.03	-38.51	-72.45
Operating Cash Flow	524.08	-8.31	104.16	-541.27	-641.69
Capital Expenditures	-58.7	-34.28	-62.21	-72.06	-76.37
Purchases of Investments	-1,365	-1,712	-1,882	-2,075	-1,698
Proceeds from Sale of Investments	1,862	1,630	1,612	2,322	1,506
Other Investing Activities	-2.15	-0.12	-4.44	-4.69	-4.2
Investing Cash Flow	436.33	-116.84	-336.35	169.35	-273.3
Long-Term Debt Issued	645.69	-	-	1,016	500
Long-Term Debt Repaid	1,155	-	-	762.11	-
Net Long-Term Debt Issued (Repaid)	1,801	-	-	1,778	500
Issuance of Common Stock	250.03	302.95	147.46	259.36	246.27
Net Common Stock Issued (Repurchased)	250.03	302.95	147.46	259.36	246.27
Other Financing Activities	-46	-8.79	24.67	-87.61	500.85
Financing Cash Flow	-305.19	294.16	172.13	425.75	1,247
Effect of Exchange Rate Changes on Cash and Cash Equivalents	34.94	-15.24	6.39	-7.43	-9.02
Net Cash Flow	690.16	153.77	-53.67	46.4	323.11
Free Cash Flow	465.38	-42.59	41.95	-613.33	-718.07
FCF Margin	12.53%	-1.89%	2.29%	-59.12%	-85.05%
Free Cash Flow Per Share	3.46	-0.33	0.34	-5.04	-6.06
Levered Free Cash Flow	2,026	-383.3	-303.2	672.69	-442.65
Unlevered Free Cash Flow	399.12	-235.52	-149.51	-762.35	-799.05

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q